Human Plasma Metabolomics For Identifying Differential Metabolites And Predicting Molecular Subtypes Of Breast Cancer

ONCOTARGET(2016)

引用 84|浏览27
暂无评分
摘要
Purpose: This work aims to identify differential metabolites and predicting molecular subtypes of breast cancer (BC).Methods: Plasma samples were collected from 96 BC patients and 79 normal participants. Metabolic profiles were determined by liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry based on multivariate statistical data analysis.Results: We observed 64 differential metabolites between BC and normal group. Compared to human epidermal growth factor receptor 2 (HER2)-negative patients, HER2-positive group showed elevated aerobic glycolysis, gluconeogenesis, and increased fatty acid biosynthesis with reduced Krebs cycle. Compared with estrogen receptor (ER)-negative group, ER-positive patients showed elevated alanine, aspartate and glutamate metabolism, decreased glycerolipid catabolism, and enhanced purine metabolism. A panel of 8 differential metabolites, including carnitine, lysophosphatidylcholine (20: 4), proline, alanine, lysophosphatidylcholine (16: 1), glycochenodeoxycholic acid, valine, and 2-octenedioic acid, was identified for the classification of BC subtypes. These markers showed potential diagnostic value with average area under the curve at 0.925 (95% CI 0.867-0.983) for the training set (n=51) and 0.893 (95% CI 0.847-0.939) for the test set (n=45).Conclusion: Human plasma metabolomics is useful in identifying differential metabolites and predicting breast cancer subtypes.
更多
查看译文
关键词
human plasma metabolomics, differential metabolites, molecular subtypes, breast cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要